Asthma Clinical Trials in Philadelphia

Showing 281-300 of 406 trials

Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects

NCT00331058

The primary goal of this study is to compare the expression of key GSK drug targets across the 4 asthma phenotypes and healthy subjects and secondarily to evaluate changes in target expression in response to a 2-week course of corticosteroids across the 4 asthma phenotypes. Each asthmatic subject in this study will undergo two bronchoscopies. Each healthy subject will undergo one bronchoscopy.

Asthma

GlaxoSmithKline58 participantsStarted Feb 2006

Winston-Salem, North Carolina, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma

NCT00048022

The primary objective of the study is to evaluate the anti-inflammatory action and safety of Ro 27-2441 (study drug) in asthmatic patients currently taking inhaled corticosteroids. The research is being conducted at up to 40 clinical research sites in the US. Study participants will have a number of visits to a research site over a 4-month period.

Asthma

Hoffmann-La RocheStarted Oct 2002

Huntington Beach, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +57 more locations

Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects

Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma

Asthma Trials in Other Cities

A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication

Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents

Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma

Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma

Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma

Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily

Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations

A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma

A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication

Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma

Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation (ProCCESs AWARE)

Inhaled Nitric Oxide Study for Respiratory Failure in Newborns

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients

Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics

Alendronate to Prevent Loss of Bronchoprotection in Asthma

Other Conditions in Philadelphia